MedTrace Logo

ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)

NCT04480151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2021-07-07

No results posted yet for this study

Summary

In this retrospective observational multicenter study the authors tested the hypothesis that the use of IMPELLA™ pump as bridge to bridge, by giving the opportunity of active rehabilitation, should improve patient's outcomes after the implantation of Left Ventricular Assist Device (LVAD).

Conditions

  • Cardiogenic Shock
  • End-stage Heart Failure

Interventions

OTHER

standard of care

retrospective study: standard of care

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Alexandre OUATTARA, MD, PhD · University Hospital, Bordeaux

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-20
Primary Completion
2021-04-21
Completion
2021-04-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04480151 on ClinicalTrials.gov